No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NGVT240719P45000
- 3.18
- +0.63+24.71%
15min DelayClose Jul 1 16:00 ET
3.18High3.18Low
3.18Open2.55Pre Close4 Volume9 Open Interest45.00Strike Price1.27KTurnover33.98%IV0.85%PremiumJul 19, 2024Expiry Date2.82Intrinsic Value100Multiplier17DDays to Expiry0.36Extrinsic Value100Contract SizeAmericanOptions Type-0.7921Delta0.0958Gamma13.61Leverage Ratio-0.0215Theta-0.0128Rho-10.78Eff Leverage0.0266Vega
Intraday
- 5D
- Daily
News
Allegion Appoints Stacy Cozad as New General Counsel
Ingevity Announces Executive Leadership Transition and Agreement
Global Activated Carbon Market Analysis and Forecast, 2024-2034 With Cabot, KURARAY, JACOBI CARBONS, Haycarb, Ingevity, and Albemarle Leading the $5+ Billion Industry - ResearchAndMarkets.com
Ingevity (NYSE:NGVT Investor Five-year Losses Grow to 55% as the Stock Sheds US$89m This Past Week
Ingevity Releases 2023 Sustainability Report, Details Commitment to Actions and Product Innovations That Enable a More Sustainable World
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Maintains Target Price $55
Comments
Ingevity's stock's poor performance over the past year and the annualized loss of 9% over the last half decade may indicate unresolved challenges. Contrarian investors might research the stock in hope of a turnaround.
Even After Rising 7.7% This Past Week, Ingevity (NYSE:NGVT) Shareholders Are Still Down 56% Over the Past Five Years 2
The lack of Ingevity insider buying and not particularly high level of insider ownership do not provide much encouragement. Be aware of the risks facing this company.
Ingevity's respectable ROE may be misleading due to high debt usage, potentially increasing future risk. High ROE doesn't always signify profitability, especially with high debt. Future profit growth and required investment should also be considered.
Ingevity's earnings are contracting and expected to fall more, explaining its low P/E ratio. There's potential for lower P/E if profitability doesn't improve, making a significant share price rise hard to foresee.
Ingevity seems to be undervalued considering its optimistic future profit outlook. Entering or adding holdings could be beneficial, yet investors should also weigh in factors such as management performance and risk profiles.
Read more